187 related articles for article (PubMed ID: 19958116)
1. Cyclosporine a-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes.
Gökçe EH; Sandri G; Eğrilmez S; Bonferoni MC; Güneri T; Caramella C
Curr Eye Res; 2009 Nov; 34(11):996-1003. PubMed ID: 19958116
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
Gokce EH; Sandri G; Bonferoni MC; Rossi S; Ferrari F; Güneri T; Caramella C
Int J Pharm; 2008 Nov; 364(1):76-86. PubMed ID: 18725276
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery.
Başaran E; Demirel M; Sirmagül B; Yazan Y
J Microencapsul; 2010; 27(1):37-47. PubMed ID: 19545226
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.
Aksungur P; Demirbilek M; Denkbaş EB; Vandervoort J; Ludwig A; Unlü N
J Control Release; 2011 May; 151(3):286-94. PubMed ID: 21241752
[TBL] [Abstract][Full Text] [Related]
5. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
Ye J; Wang Q; Zhou X; Zhang N
Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
[TBL] [Abstract][Full Text] [Related]
6. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.
Shen J; Deng Y; Jin X; Ping Q; Su Z; Li L
Int J Pharm; 2010 Dec; 402(1-2):248-53. PubMed ID: 20934499
[TBL] [Abstract][Full Text] [Related]
7. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
8. [The pharmacokinetics of FK506 and its nanoparticles in aqueous humor of rabbits].
Fei WL; Chen JQ; Zhong SL; Liu YM; Pang ZQ; Wang Z; Yuan J; Ye CT
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):305-8. PubMed ID: 16762205
[TBL] [Abstract][Full Text] [Related]
9. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK
Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
[TBL] [Abstract][Full Text] [Related]
10. Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles.
Hu L; Jia H; Luo Z; Liu C; Xing Q
Pharmazie; 2010 Feb; 65(2):110-3. PubMed ID: 20225654
[TBL] [Abstract][Full Text] [Related]
11. A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide.
Li R; Jiang S; Liu D; Bi X; Wang F; Zhang Q; Xu Q
J Microencapsul; 2011; 28(2):134-41. PubMed ID: 21142697
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery.
Lv Q; Yu A; Xi Y; Li H; Song Z; Cui J; Cao F; Zhai G
Int J Pharm; 2009 May; 372(1-2):191-8. PubMed ID: 19429280
[TBL] [Abstract][Full Text] [Related]
13. [Comparison between local and systemic administration of cyclosporin A on the effective level in conjunctiva, aqueous humor and serum].
Pfau B; Kruse FE; Rohrschneider K; Zorn M; Fiehn W; Burk RO; Völcker HE
Ophthalmologe; 1995 Dec; 92(6):833-9. PubMed ID: 8563433
[TBL] [Abstract][Full Text] [Related]
14. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].
Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM
Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107
[TBL] [Abstract][Full Text] [Related]
15. Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles.
Castro GA; Coelho AL; Oliveira CA; Mahecha GA; Oréfice RL; Ferreira LA
Int J Pharm; 2009 Oct; 381(1):77-83. PubMed ID: 19647057
[TBL] [Abstract][Full Text] [Related]
16. Development of SLNs from natural lipids: application to topical delivery of tretinoin.
Mandawgade SD; Patravale VB
Int J Pharm; 2008 Nov; 363(1-2):132-8. PubMed ID: 18657601
[TBL] [Abstract][Full Text] [Related]
17. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
Müller RH; Runge S; Ravelli V; Mehnert W; Thünemann AF; Souto EB
Int J Pharm; 2006 Jul; 317(1):82-9. PubMed ID: 16580159
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of terbinafine in the rabbit ocular tissues after topical administration.
Sun XG; Wang ZX; Wang ZQ; Deng SJ; Li R; Luo SY; Wu YY
Ophthalmic Res; 2007; 39(2):81-3. PubMed ID: 17284933
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
